Palmitoyl Pentapeptide-4 (Matrixyl) vs Snap-8
Collagen-boosting signal peptide clinically proven to reduce wrinkles and fine lines in photoaged skin.
An advanced 8-amino-acid peptide that relaxes facial muscles from the outside in—think of it as 'Botox in a bottle' that you apply to your skin to smooth expression lines without needles or injections.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Quick comparison
Dose range
Palmitoyl Pentapeptide-4 (Matrixyl)
0.012–0.012 %
Snap-8
10–10 %
Frequency
Palmitoyl Pentapeptide-4 (Matrixyl)
Once daily
Snap-8
Once daily
Administration
Palmitoyl Pentapeptide-4 (Matrixyl)
Topical
Snap-8
Topical application
Cycle length
Palmitoyl Pentapeptide-4 (Matrixyl)
Ongoing/indefinite
Snap-8
Ongoing/indefinite
Onset speed
Palmitoyl Pentapeptide-4 (Matrixyl)
Moderate (1-2 weeks)
Snap-8
Moderate (1-2 weeks)
Evidence level
Palmitoyl Pentapeptide-4 (Matrixyl)
Limited human trials
Snap-8
Moderate human trials (Phase 1-2)
Benefit ratings
Anti-Wrinkle
Collagen Production
Skin Rejuvenation
Wrinkle Reduction
Muscle Relaxation
Skin Smoothing
Compound specifications
Palmitoyl Pentapeptide-4 (Matrixyl)
Molecular formula
C39H75N7O10
Molecular weight
802.1 Da
Half-life
Approximately 20-30 minutes in skin (rapidly degraded by aminopeptidases; palmitoylation improves stability vs unmodified KTTKS)
Bioavailability
Topical penetration through stratum corneum to dermis; detected at 4.2 µg/cm² in SC, 2.8 µg/cm² in epidermis, 0.3 µg/cm² in dermis
CAS number
214047-00-4
Snap-8
Molecular formula
C41H70N16O16S
Molecular weight
1075.16 g/mol
Half-life
Topical activity persists 12-24 hours on skin
Bioavailability
Penetrates stratum corneum; reaches viable epidermis with appropriate formulation
CAS number
868844-74-0
Dosing compared
Palmitoyl Pentapeptide-4 (Matrixyl)
Topical
3 ppm (0.0003%) active peptide
Twice daily · 12 weeks
The dose with proven clinical results: a randomized controlled trial (n=93) showed visible improvement in photoaged facial skin at 3 ppm of active Pal-KTTKS applied twice daily over 12 weeks [1]. This is the active-peptide concentration, not the trade solution.
Up to 0.012% in finished product
Twice daily · Ongoing
Typical concentration range found in commercial leave-on anti-aging products, considered safe for cosmetic use by industry review [6]. Higher than the minimum clinical dose but well within the safety-assessed range.
Snap-8
Topical
3-5% of supplied peptide solution in formulation
Once to twice daily · 4 weeks initial trial
Source class: manufacturer recommendation, not peer-reviewed clinical data. Lipotec/Lubrizol recommends 3-10% of supplied peptide solution in formulations [1][2]. No peer-reviewed study has tested any specific concentration of Snap-8 alone in a topical formulation.
10% of supplied peptide solution in formulation
Twice daily · Ongoing use
Source class: manufacturer recommendation, not peer-reviewed clinical data. Lipotec/Lubrizol recommends up to 10% concentration [1][2]. The wrinkle-reduction percentages attributed to this concentration (such as 63%) originate from manufacturer datasheets, not peer-reviewed publications, and have not been independently verified.
Best suited for
Palmitoyl Pentapeptide-4 (Matrixyl)
Individuals seeking non-invasive anti-wrinkle treatment
Palmitoyl Pentapeptide-4 (Matrixyl) is particularly well-suited for individuals focused on individuals seeking non-invasive anti-wrinkle treatment. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Those with photoaged skin showing fine lines and loss of firmness
Palmitoyl Pentapeptide-4 (Matrixyl) is particularly well-suited for individuals focused on those with photoaged skin showing fine lines and loss of firmness. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
People looking to boost collagen production through topical skincare
Palmitoyl Pentapeptide-4 (Matrixyl) is particularly well-suited for individuals focused on people looking to boost collagen production through topical skincare. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Sensitive skin types seeking well-tolerated anti-aging actives
Palmitoyl Pentapeptide-4 (Matrixyl) is particularly well-suited for individuals focused on sensitive skin types seeking well-tolerated anti-aging actives. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Snap-8
Expression Line Fighters
If you've noticed those lines that form when you smile, frown, or squint are starting to stick around even when your face is relaxed, Snap-8 is designed exactly for this. It works on the muscle-skin connection that creates these dynamic wrinkles.
Botox-Curious but Needle-Shy
Love the idea of smoother skin but not ready for injections? Snap-8 offers a topical alternative that works through a similar mechanism as Botox—just gentler and without the commitment. Perfect for testing the waters of muscle-relaxing anti-aging.
Prevention-Focused Millennials
Starting in your late 20s or early 30s with preventive skincare? Snap-8 can help keep expression lines from becoming permanent fixtures by calming the repetitive muscle movements that eventually etch wrinkles into your skin.
Sensitive Skin Types
Unlike some anti-aging actives that can be harsh, Snap-8 is remarkably well-tolerated. If retinoids make your skin angry or acids cause irritation, peptides like Snap-8 offer effective anti-aging without the drama.
Side effects
Palmitoyl Pentapeptide-4 (Matrixyl)
Common
- Mild Tingling
- Transient Redness
- Dryness with Exfoliants
- Mild Irritation
Uncommon
- Contact Dermatitis
Serious
- Excessive Collagen Synthesis and Scar Risk
Snap-8
Common
- Mild tingling sensation
- Temporary redness
- Skin dryness
Uncommon
- Contact irritation
- Skin tightness
Serious
- Allergic reaction
Safety & evidence
Palmitoyl Pentapeptide-4 (Matrixyl)
Evidence level
Limited human trials
FDA status
Research compound
Safety overview
Palmitoyl pentapeptide-4 (Matrixyl) demonstrates excellent dermatological safety with GRAS/safe-for-cosmetic status; extensively used in anti-aging skincare for 20+ years with no serious adverse events. Skin irritation potential is minimal at recommended 2-3% concentrations (irritation index <0.5). No systemic absorption via intact skin; confined to epidermis/dermis per Franz diffusion cell studies. Stability in formulations verified through HPLC analysis.
Contraindications
- Known hypersensitivity to palmitoyl pentapeptide-4 or formulation excipients
- Active skin infections at the application site
- Severely compromised skin barrier with open wounds
- No known systemic contraindications at cosmetic concentrations
Snap-8
Evidence level
Moderate human trials (Phase 1-2)
FDA status
Not FDA approved
Safety overview
No peer-reviewed study has tested Snap-8 (acetyl octapeptide-3) alone for safety or efficacy. The compound has been included in two published multi-component microneedle patch studies, both of which combined it with several other active ingredients. Avcil et al. (2020) tested a hyaluronic acid microneedle patch loaded with acetyl octapeptide-3 plus palmitoyl tripeptide-5, adenosine, and seaweed extracts in a 12-week monocentric trial on the eye area. None of the subjects reported any primary or cumulative skin reactions [1]. Shin et al. (2024) tested a dissolving microneedle patch containing acetyl octapeptide-3, L-ascorbic acid 2-glucoside, and sodium cyclic lysophosphatidic acid in 24 subjects over 28 days (patch vs placebo on opposite eyes). No adverse effects were reported [2]. In both studies, multiple active ingredients were present — adverse effects cannot be attributed to or excluded from Snap-8 specifically. An FDA in vitro study of the related compound acetyl hexapeptide-8 (Argireline, 6 amino acids vs Snap-8's 8) found that the peptide remains mostly in the stratum corneum (0.22% of applied dose in human skin) with none reaching the dermis, supporting low systemic exposure for topical SNARE-interfering peptides [4].
Contraindications
- Known allergy to peptide ingredients
- Active skin infections at application site
- Open wounds or severe skin irritation
- Pregnancy (as a precaution due to limited data)
Which is right for you?
Choose Palmitoyl Pentapeptide-4 (Matrixyl) if...
- Individuals seeking non-invasive anti-wrinkle treatment
- Those with photoaged skin showing fine lines and loss of firmness
- People looking to boost collagen production through topical skincare
- Sensitive skin types seeking well-tolerated anti-aging actives
Choose Snap-8 if...
- Wrinkle reduction
- Expression line smoothing
- Preventive anti-aging
- Non-invasive cosmetic enhancement